Wednesday, 11 December 2013

The MS Trust is disappointed that NICE does not intend to recommend that alemtuzumab (Lemtrada)

Source MS Trust:
The MS Trust is disappointed that NICE does not intend to recommend that alemtuzumab (Lemtrada) be made available as a treatment on the NHS in England and Wales.

In the appraisal consultation document published on the NICE website today (5 December), the appraisal committee's preliminary recommendations state: Read on